Diabetes

Evolocumab safe, effective for those with dysglycemia, MetS

(HealthDay)—For patients with or without dysglycemia or metabolic syndrome (MetS), evolocumab is safe and efficacious for reducing low-density lipoprotein cholesterol at 52 weeks, according to research published online ...

Diabetes

Water may be an effective treatment for metabolic syndrome

Researchers at the University of Colorado Anschutz Medical Campus have discovered that fructose stimulates the release of vasopressin, a hormone linked to obesity and diabetes. They also found that water can suppress the ...

page 7 from 40